Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 04, 2026
Tuesday Analyst Upgrades and Downgrades: Campbell Soup, Exact Sciences, Exelixis, Spirit Airlines, Sarepta, ZTO and More
09:11am, Tuesday, 15'th Jun 2021
Tuesday's futures were fairly positive after a somewhat mixed start to the week.
Exact Sciences (EXAS) Down 1.4% Since Last Earnings Report: Can It Rebound?
12:47pm, Thursday, 03'rd Jun 2021
Exact Sciences (EXAS) reported earnings 30 days ago. What's next for the stock?
Here's Why You Should Hold on to Exact Sciences (EXAS) Stock
10:31am, Wednesday, 26'th May 2021
Investors are optimistic about Exact Sciences (EXAS) on solid first-quarter performance and strategic partnerships.
Exact Sciences (EXAS) Reveals Promising Data on Cologuard
08:16am, Wednesday, 26'th May 2021
Modeling data exhibits efficacy of Exact Sciences' (EXAS) Cologuard compared to FIT and other colorectal cancer diagnostic options.
4 Unstoppable Healthcare Stocks to Buy on the Dip
06:05am, Wednesday, 26'th May 2021
They're well below peak levels set earlier this year. But they could be huge winners over the long run.
Boston Scientific, Gap, Molson Coors and More Tuesday Afternoon Analyst Calls
12:12pm, Tuesday, 25'th May 2021
With the trading day more than halfway over, the markets had dipped after a relatively strong start to the day.
Exact Sciences to participate in June investor conferences
06:00am, Monday, 24'th May 2021
MADISON, Wis., May 24, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following virtual conferences and invited investors to
MADISON, Wis., May 21, 2021 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today highlights data from one oral and one poster presentation being featured at the 2021 Digestive Disease Week® (
Strength Seen in Exact Sciences (EXAS): Can Its 9.2% Jump Turn into More Strength?
07:31am, Friday, 21'st May 2021
Exact Sciences (EXAS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more stre
Why Exact Sciences Stock Soared Today
03:51pm, Thursday, 20'th May 2021
The company's Cologuard DNA test appears to be in good shape to maintain its market leadership.
MADISON, Wis., May 19, 2021 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a global leader in cancer diagnostics, today announced new data on its cancer tests and treatment guidance tools will b
Are You a Glass Half Full or Half Empty Investor?
02:17pm, Wednesday, 19'th May 2021
Buying the stock market weakness? Or staying on the sidelines?
Exact Sciences Applauds Final Task Force Recommendation That Lowers Starting Age for Colorectal Cancer Screening to 45
08:05pm, Tuesday, 18'th May 2021
MADISON, Wis., May 18, 2021 /PRNewswire/ -- The United States Preventive Services Task Force (USPSTF) today released its final colorectal cancer screening recommendation that screening begin at age 45
Exact Sciences: Emerging Leader In Cancer Screening
10:00am, Tuesday, 18'th May 2021
Emerging early cancer diagnostics company with innovative products and the potential to disrupt conventional screening methods. Strong pipeline of future products along with promising growth in recurr
Exact Sciences' First-Quarter Results Show Its Strength Under Pressure
06:39am, Saturday, 15'th May 2021
Despite ongoing pandemic-related headwinds, the medical diagnostic test maker's revenue grew. So how will it perform as those headwinds dissipate?
